Subcategory Detail
Interagency Autism Coordinating Committee (IACC) logo
Office of Autism Research Coordination (OARC) logo

Medical/Pharmacologic$10,960,296.00
Fiscal Year: 2010
  

Download 2010 Medical/Pharmacologic projects (EXCEL)
This subcategory includes research on drugs (e.g., antidepressants, anticonvulsants, antipsychotics, anxiolytics, melatonin, and stimulants) to treat autism and its co-occurring conditions, as well as medical therapies such as transcranial magnetic stimulation (TMS).
Graph: The subcategories for Question 4 illustrate the many approaches to treatments and interventions supported by autism research funders. The largest amount of funding supported projects to develop Model systems and therapeutic targets (35%), followed by research on Behavioral interventions (29%). Medical/Pharmacologic interventions received 16% of funding, classroom-based interventions (Educational) received 10% of funding, and Technology-based interventions and supports received 7% of funding. The subcategories with the smallest amounts of funding included Occupational, physical, and sensory-based (2%) and Complementary, dietary, and alternative (1%).
Note: Initial Sort is by Principal Investigator. Sorting by other columns is available by clicking on the desired column header.
Project Title Principal Investigator Strategic Plan Objective Institution
4/4-RUPP Autism Network: Guanfacine for the treatment of hyperactivity in PDD Scahill, Lawrence Q4.L.C Yale University
Pharmacotherapy of pervasive developmental disorders Stigler, Kimberly Q4.L.C Indiana University-Purdue University Indianapolis
Targeted pharmacologic interventions for autism McDougle, Christopher Q4.L.C Indiana University-Purdue University Indianapolis
Survey on treatment for children with autism with and without seizures Frye, Richard Q4.Other Children's Learning Institute
Building a selective inhibitory control tone in autism: An rTMS study Casanova, Manuel Q4.Other University of Louisville